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parietal tumor localization was a predictor for a higher 
contralateral hippocampal dose (p=0.01). 
 
Conclusion: A substantial reduction of the dose to the 
contralateral hippocampus is technically feasible when VMAT 
is used instead of our standard 3D-CRT planning strategy. The 
amount of sparing that can be achieved strongly depends on 
the individual patient geometry. Whether this approach is 
able to conserve the neurocognitive status without 
compromising the oncological outcome for patients with 
glioblastoma needs to be investigated in the setting of 
prospective clinical trials. 
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Purpose or Objective: Bone metastases are a frequent and 
disturbing complication of cancer. The challenge of 
optimizing dose coverage of the concave shape of the sacrum 
along with its close proximity to the rectum, intestines and 
femoral heads lead us to investigate whether the VMAT 
technique is advantageous when compared to 3D treatment. 
 
Material and Methods: Twenty three consecutively treated 
patients with sacral metastases in 2013-2014 were included 
in a comparative treatment-planning study evaluating VMAT 
and 3-D planning. The statistical analysis included the T- 
test, assuming Unequal Variance (one tail). Calculation of the 
p-value for the comparative results applied. Our null 
hypothesis was that VMAT is better than 3D technique, and 
our alternative hypothesis was that 3D technique is superior 
to VMAT. 
 
Results: The PTV coverage was identical in VMAT and 3D 
planning. Median values and V15 for the intestinal exposure 
showed no statistically significant difference between the 3D 
planning and VMAT: 9.28 Gy (SD 2.25) and 47.0 ml (SD 68.62) 
versus 8.97 Gy (SD 2.18) and 18.45 ml (SD 69.56), 
respectively. However, on an individual per case assessment 
it appears that the lower exposure of the bowel depends on 
the small bowel/ sacrum volumes ratio. The benefit for VMAT 
emerges if such a ratio exceeds one. The median values for 
the rectum 3D and VMAT were 11.34 Gy (SD 5.14) and 7.7 Gy 
(SD 2.76), respectively. The median 3D and VMAT exposure of 
the femoral head were 1.78 (SD 2.94) Vs 4.006 (SD 2.1) on 
the left and 1.74 (0.9) Vs 4.26 (SD 1.8) on the right side for 
the 3D and VMAT, respectively. 
 
Conclusion: Good sacral coverage is achievable with either 3-
D or VMAT approaches. VMAT is advantageous vis-à-vis the 
rectal exposure and when relatively large amounts of small 
bowel course through an individual patient's fields. The 3-D 
approach, however, retains benefit for femoral protection, a 
finding that may have implications for patients with arthritis 
and osteopenia. 
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Purpose or Objective: In Conventional Radiotherapy (CRT), 
Total Body Irradiation (TBI) is generally performed at long 
Source Skin Distance using diodes to drive the delivered dose. 
The dose distribution is usually not well assessed (measured 
only in a few points) and was shown to be strongly 
heterogeneous. This technique also leads to acute and late 
toxicity. Helical Tomotherapy (Accuray Inc., Sunnyvale, CA) 
for TBI is implemented in some centers. Compared to CRT, 
Tomotherapy allows the delivery of the prescribed dose with 
a high level of accuracy and homogeneity. Organs-at-risk can 
be spared and the dose distribution is known before the 
treatment. Two technical issues have to be solved. First, the 
patient must be treated using two plans, head first (HF) and 
feet first (FF) due to limited supero-inferior (SI) table 
motion. At the junction of these two plans, the dose must be 
delivered with particular care. Moreover, the planning target 
volume (PTV) is the entire body, including the skin. A safety 
margin in the air surrounding the body should be added to 
take into account setup errors. Using inverse planning, 
however, can result in over-fluence peaks in the skin region. 
The aim of this work is to present our solution for these two 
issues, our optimized planning protocol and our clinical 
results after one year of practice (outcome for 15 patients). 
 
Material and Methods: Patient treatment position is shown 
hereafter. Thermoplastic masks are placed on the head and 
the thorax (not the legs). Two CTs are acquired (HF and FF). 
At the planning station, the whole body (cropped 3 mm under 
the skin) is divided into 10 PTVs. At the junction (~halfway up 
the thighs), 4 PTVs (thickness 2 cm) are drawn to deliver the 
dose with the degraded penumbra methodology: decreased 
dose is delivered during HF plan and increased dose during FF 
plan. Different sets of doses were tested. The resulting dose 
distribution in the presence of simulated set-up errors (SSUE) 
is computed to find the combination that insures optimal 
dose coverage of the junction. Moreover, to insure dose 
coverage of legs in presence of SSUE, several Virtual Boluses 
(VB) were tested. A VB is a bolus added at planning, but not 
present during treatment. Several thicknesses and densities 
were tested on a phantom study: in presence of SSUE, the 
dose coverage and dose increase (due to the methodology) 
were assessed. 
 
 
 
Results: The best combination of PTV doses at the junction is 
presented in table: V95% stays higher than 96% even in the 
case of a SSUE of 1 cm (SI). The optimal VB is an 8 mm thick 
VB (density=0.4). This allows a good coverage (V95%>95%) for 
a large lateral SSUE (up to 2.9 cm). Underestimation of dose 
using this VB (planning vs measure) is 1.5%. 
 
 
Conclusion: This study presents our optimized planning 
parameters. Since November 2014, 15 patients were treated 
with a dose of 2 or 12 Gy. Dose to lungs was limited to 9 Gy. 
